| scholarly article | Q13442814 |
| P50 | author | Hilary G. Morrison | Q30511933 |
| Mitchell Sogin | Q30594851 | ||
| Susan M Huse | Q87065534 | ||
| Thomas M. Schmidt | Q46832703 | ||
| P2093 | author name string | Vincent B Young | |
| Dionysios A Antonopoulos | |||
| P2860 | cites work | Microbial ecology of the gastrointestinal tract | Q22255628 |
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism | Q24548304 | ||
| MUSCLE: multiple sequence alignment with high accuracy and high throughput | Q24613456 | ||
| Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine | Q24648636 | ||
| Microbial diversity in the deep sea and the underexplored "rare biosphere" | Q24685531 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
| Host-bacterial mutualism in the human intestine | Q27861037 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| A molecular view of microbial diversity and the biosphere | Q28235782 | ||
| Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes | Q28268854 | ||
| Evolution of mammals and their gut microbes | Q28755326 | ||
| Ecological and evolutionary forces shaping microbial diversity in the human intestine | Q29547586 | ||
| Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 | ||
| Microbial influences in inflammatory bowel diseases | Q29614264 | ||
| Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness | Q29614293 | ||
| The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing | Q29615054 | ||
| Accuracy and quality of massively parallel DNA pyrosequencing | Q29622857 | ||
| Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria | Q33238568 | ||
| Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice | Q73838431 | ||
| Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set | Q77465460 | ||
| In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests | Q79407896 | ||
| Probiotics: definition, sources, selection, and uses | Q80463721 | ||
| Quantifying biodiversity: procedures and pitfalls in the measurement and comparison of species richness | Q104206763 | ||
| Microbial population structures in the deep marine biosphere | Q33301618 | ||
| Gastrointestinal microbiology enters the metagenomics era. | Q33307488 | ||
| An antibiotic-responsive mouse model of fulminant ulcerative colitis | Q33322360 | ||
| Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases | Q33341563 | ||
| Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection | Q33357471 | ||
| Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing | Q33385985 | ||
| Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. | Q33718086 | ||
| Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube | Q33964412 | ||
| Assembly of the human intestinal microbiota | Q33997399 | ||
| Clostridium difficile--Associated diarrhea: A review | Q34185015 | ||
| Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits | Q34596030 | ||
| A mouse model of Clostridium difficile-associated disease | Q34598259 | ||
| Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea | Q34736772 | ||
| Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii | Q35023584 | ||
| Human colonic biota studied by ribosomal DNA sequence analysis. | Q35191757 | ||
| Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress | Q35219967 | ||
| Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease | Q35220907 | ||
| Bacterial modulation of mucosal innate immunity | Q36097463 | ||
| A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem | Q36436689 | ||
| Recurrent clostridium difficile | Q36450803 | ||
| Probiotics and chronic disease | Q36457622 | ||
| Debugging how bacteria manipulate the immune response. | Q36739044 | ||
| Colloquium paper: resistance, resilience, and redundancy in microbial communities | Q36915414 | ||
| Historical perspectives on studies of Clostridium difficile and C. difficile infection | Q37051305 | ||
| Mechanisms of action of probiotics | Q37053062 | ||
| Rules of engagement: interspecies interactions that regulate microbial communities | Q37187806 | ||
| The "Microflora Hypothesis" of allergic disease | Q37289362 | ||
| Colonization resistance | Q40285153 | ||
| The microecology of Clostridium difficile | Q40822054 | ||
| In vivo and in vitro antagonism of intestinal bacteria against Shigellaflexneri. II. The inhibitory mechanism | Q43569926 | ||
| Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice | Q46713769 | ||
| Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile | Q46798068 | ||
| Long-term ecological impacts of antibiotic administration on the human intestinal microbiota | Q46878665 | ||
| Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction | Q49225672 | ||
| Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients | Q69370183 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reproducibility | Q1425625 |
| antibiotic | Q12187 | ||
| community dynamics | Q121886851 | ||
| P304 | page(s) | 2367-2375 | |
| P577 | publication date | 2009-03-23 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation | |
| P478 | volume | 77 |
| Q47136356 | 47 Years of IAI: a Glance in the Mirror and the Road Ahead |
| Q64976006 | A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model. |
| Q26795697 | A Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent Models |
| Q33518563 | A high-throughput DNA sequence aligner for microbial ecology studies |
| Q41325775 | A single early-in-life macrolide course has lasting effects on murine microbial network topology and immunity. |
| Q50002126 | A study of the dynamics of Salmonella infection in turkey breeding, rearing and finishing houses with special reference to elimination, persistence and introduction of Salmonella |
| Q50770183 | Abundance of antibiotics, antibiotic resistance genes and bacterial community composition in wastewater effluents from different Romanian hospitals. |
| Q35668145 | Activation of the cryptic PhnE permease promotes rapid adaptive evolution in a population of Escherichia coli K-12 starved for phosphate |
| Q33644355 | Additive effect between IL-13 polymorphism and cesarean section delivery/prenatal antibiotics use on atopic dermatitis: a birth cohort study (COCOA). |
| Q34675803 | Agent Based Modeling of Human Gut Microbiome Interactions and Perturbations. |
| Q21562196 | Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients |
| Q44537620 | Alteration of microbial community structure affects diesel biodegradation in an Arctic soil |
| Q35109773 | Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection |
| Q34222268 | Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus |
| Q36260713 | Altered Gut Microbiota Composition in Rag1-deficient Mice Contributes to Modulating Homeostasis of Hematopoietic Stem and Progenitor Cells |
| Q29394736 | Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences |
| Q46475751 | Amoxicillin-clavulanic acid and ciprofloxacin-treated SPF mice as gnotobiotic model. |
| Q91072457 | An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model |
| Q35273138 | Anaerobic respiration of Escherichia coli in the mouse intestine |
| Q34024986 | Analysis of streptococcal CRISPRs from human saliva reveals substantial sequence diversity within and between subjects over time. |
| Q27335185 | Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class |
| Q47148830 | Antibiotic Treatment Induces Long-lasting Changes in the Fecal Microbiota that Protect Against Colitis |
| Q41865163 | Antibiotic administration alters the community structure of the gastrointestinal micobiota. |
| Q42516402 | Antibiotic pretreatment minimizes dietary effects on reconstructure of rumen fluid and mucosal microbiota in goats. |
| Q36660833 | Antibiotic resistance shaping multi-level population biology of bacteria |
| Q37333331 | Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts |
| Q40198098 | Antibiotic use before chemotherapy: a risk factor for developing neutropenic colitis in children with leukemia |
| Q55407461 | Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. |
| Q92757722 | Antibiotic-induced dysbiosis of gut microbiota impairs corneal development in postnatal mice by affecting CCR2 negative macrophage distribution |
| Q90191639 | Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress |
| Q93073764 | Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain |
| Q30066419 | Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection |
| Q57803113 | Antibiotics and autoimmune and allergy diseases: Causative factor or treatment? |
| Q35737454 | Antibiotics and the developing infant gut microbiota and resistome |
| Q37908453 | Antibiotics and the resistant microbiome |
| Q44447065 | Antibiotics conspicuously affect community profiles and richness, but not the density of bacterial cells associated with mucosa in the large and small intestines of mice |
| Q59590839 | Antibiotics in early life: dysbiosis and the damage done |
| Q34086534 | Antibiotics in feed induce prophages in swine fecal microbiomes |
| Q36188444 | Antibiotics, microbiota, and immune defense |
| Q38784946 | Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice |
| Q64987769 | Antimicrobial Effects on Swine Gastrointestinal Microbiota and Their Accompanying Antibiotic Resistome. |
| Q93129521 | Aryl hydrocarbon receptor ligands enhance lung immunity through intestinal IKKβ pathways |
| Q92135336 | Association between extrauterine growth restriction and changes of intestinal flora in Chinese preterm infants |
| Q91541157 | Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics |
| Q43966192 | Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy |
| Q92391040 | Attenuation of immune-mediated bone marrow damage in conventionally housed mice |
| Q34027004 | Bacterial community characteristics under long-term antibiotic selection pressures |
| Q27024003 | Bacterial diversity and antibiotic resistance in water habitats: searching the links with the human microbiome |
| Q37627103 | Bacterial infections: new and emerging enteric pathogens |
| Q91630956 | Bacteriophage versus antibiotic therapy on gut bacterial communities of juvenile green turtle, Chelonia mydas |
| Q90265289 | Bacteriophages Reduce Pathogenic Escherichia coli Counts in Mice Without Distorting Gut Microbiota |
| Q40757720 | Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition |
| Q35134825 | Beneficial modulation of the gut microbiota. |
| Q36389113 | Beyond pairwise mechanisms of species coexistence in complex communities |
| Q34049635 | Beyond the Venn diagram: the hunt for a core microbiome |
| Q90737346 | Bile Acid Profile and its Changes in Response to Cefoperazone Treatment in MR1 Deficient Mice |
| Q40355536 | Broad spectrum antibiotic enrofloxacin modulates contact sensitivity through gut microbiota in a murine model |
| Q36277345 | Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy |
| Q49858316 | Carbohydrate composition of rat intestine surface mucus layer after ceftriaxone treatment |
| Q36878269 | Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria. |
| Q35914081 | Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains |
| Q58746132 | Changes in Gut Microbiota Prior to Influenza A Virus Infection Do Not Affect Immune Responses in Pups or Juvenile Mice |
| Q34338232 | Changes in bowel microbiota induced by feeding weanlings resistant starch stimulate transcriptomic and physiological responses. |
| Q39376284 | Changes in the bacterial microbiome of patients with chronic rhinosinusitis after endoscopic sinus surgery |
| Q35719278 | Characterization of Antibiotic Resistance Gene Abundance and Microbiota Composition in Feces of Organic and Conventional Pigs from Four EU Countries. |
| Q34584990 | Chicken faecal microbiota and disturbances induced by single or repeated therapy with tetracycline and streptomycin |
| Q30470322 | Clinical and laboratory features of Streptococcus salivarius meningitis: a case report and literature review |
| Q52564641 | Clostridium difficile - From Colonization to Infection. |
| Q55378280 | Clostridium difficile Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization. |
| Q36941569 | Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease |
| Q54964690 | Clostridium difficile alters the structure and metabolism of distinct cecal microbiomes during initial infection to promote sustained colonization |
| Q34311594 | Clostridium difficile and the microbiota |
| Q35835594 | Clostridium difficile infection and intestinal microbiota interactions |
| Q34348999 | Collateral effects of antibiotics on mammalian gut microbiomes |
| Q35973168 | Colonization Resistance of the Gut Microbiota against Clostridium difficile |
| Q96687272 | Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies |
| Q42575595 | Comparing the microbiota of the cystic fibrosis lung and human gut. |
| Q34031954 | Comparisons of clustered regularly interspaced short palindromic repeats and viromes in human saliva reveal bacterial adaptations to salivary viruses |
| Q35130121 | Contributions of intestinal bacteria to nutrition and metabolism in the critically ill |
| Q37922247 | Control of host inflammatory responsiveness by indigenous microbiota reveals an adaptive component of the innate immune system |
| Q36225836 | Critical role of microbiota within cecal crypts on the regenerative capacity of the intestinal epithelium following surgical stress |
| Q40116951 | Cross-modulation of pathogen-specific pathways enhances malnutrition during enteric co-infection with Giardia lamblia and enteroaggregative Escherichia coli |
| Q93200261 | Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices |
| Q35654999 | Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference. |
| Q30279007 | Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model |
| Q36296162 | Defining Disturbance for Microbial Ecology |
| Q36027794 | Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice |
| Q92502643 | Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates Clostridioides difficile Colonization |
| Q35696978 | Dietary administration of the probiotic SpPdp11: Effects on the intestinal microbiota and immune-related gene expression of farmed Solea senegalensis treated with oxytetracycline. |
| Q36072036 | Dietary silver nanoparticles can disturb the gut microbiota in mice |
| Q92825983 | Differential Impact of Subtherapeutic Antibiotics and Ionophores on Intestinal Microbiota of Broilers |
| Q35055063 | Differential effects of antibiotic therapy on the structure and function of human gut microbiota |
| Q39488475 | Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin |
| Q30424368 | Disruption of the human gut microbiota following Norovirus infection |
| Q35569651 | Disturbance opens recruitment sites for bacterial colonization in activated sludge. |
| Q33843648 | Diversity and population structure of sewage-derived microorganisms in wastewater treatment plant influent. |
| Q28479207 | Dogs leaving the ICU carry a very large multi-drug resistant enterococcal population with capacity for biofilm formation and horizontal gene transfer |
| Q47095282 | Doxycycline induces dysbiosis in female C57BL/6NCrl mice |
| Q63975829 | Drug-mediated metabolic tipping between antibiotic resistant states in a mixed-species community |
| Q49147519 | Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. |
| Q49501850 | Early microbiota, antibiotics and health. |
| Q47718068 | Early-Life Intestine Microbiota and Lung Health in Children |
| Q56536554 | Ecological effects of cefepime use during antibiotic cycling on the Gram-negative enteric flora of ICU patients |
| Q39914642 | Effect of Antibiotic Treatment on the Gastrointestinal Microbiome of Free-Ranging Western Lowland Gorillas (Gorilla g. gorilla). |
| Q24632558 | Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. |
| Q104615824 | Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota |
| Q101475452 | Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut Microbiota |
| Q92813494 | Effects of Early Intervention with Antibiotics and Maternal Fecal Microbiota on Transcriptomic Profiling Ileal Mucusa in Neonatal Pigs |
| Q60912936 | Effects of Early Intervention with Maternal Fecal Microbiota and Antibiotics on the Gut Microbiota and Metabolite Profiles of Piglets |
| Q36619973 | Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model |
| Q35511709 | Effects of the gut microbiota on bone mass |
| Q35107269 | Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea |
| Q99552138 | Efficacy of Sucralfate-Combined Quadruple Therapy on Gastric Mucosal Injury Induced by Helicobacter pylori and Its Effect on Gastrointestinal Flora |
| Q35058372 | Emerging roles of the microbiome in cancer |
| Q59069853 | Environment dominates over host genetics in shaping human gut microbiota |
| Q90438417 | Environmental remodeling of human gut microbiota and antibiotic resistome in livestock farms |
| Q33899721 | Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates |
| Q37014160 | Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease |
| Q92363200 | Establishing What Constitutes a Healthy Human Gut Microbiome: State of the Science, Regulatory Considerations, and Future Directions |
| Q36115254 | Evaluating robustness of a diesel-degrading bacterial consortium isolated from contaminated soil. |
| Q39113167 | Evolutionary and ecological forces that shape the bacterial communities of the human gut. |
| Q34984909 | Experimental approaches for defining functional roles of microbes in the human gut. |
| Q61807098 | Exploring the Fecal Microbial Composition and Metagenomic Functional Capacities Associated With Feed Efficiency in Commercial DLY Pigs |
| Q34574485 | Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation |
| Q57256535 | Exposure to nanoplastics disturbs the gut microbiome in the soil oligochaete Enchytraeus crypticus |
| Q48152819 | Faecal and caecal microbiota profiles of mice do not cluster in the same way. |
| Q36131743 | Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. |
| Q49670413 | Fate of potential indicator antimicrobial resistance genes (ARGs) and bacterial community diversity in simulated manure-soil microcosms |
| Q40079792 | Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile |
| Q34284553 | Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. |
| Q39294902 | Food additives, contaminants and other minor components: effects on human gut microbiota-a review. |
| Q58649249 | From Animalcules to an Ecosystem: Application of Ecological Concepts to the Human Microbiome |
| Q24612050 | From structure to function: the ecology of host-associated microbial communities |
| Q33560652 | Functional and phylogenetic assembly of microbial communities in the human microbiome |
| Q28256703 | Functional characterization of the antibiotic resistance reservoir in the human microflora |
| Q36476972 | Fundamentals of microbial community resistance and resilience |
| Q34972317 | Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment |
| Q33714049 | GROWTH AND DEVELOPMENT SYMPOSIUM: Promoting healthier humans through healthier livestock: Animal agriculture enters the metagenomics era12 |
| Q91096668 | Gastrointestinal Microbiota and Type 1 Diabetes Mellitus: The State of Art |
| Q90573245 | Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking |
| Q82207962 | Genetics and Environmental Interactions Shape the Intestinal Microbiome to Promote Inflammatory Bowel Disease Versus Mucosal Homeostasis |
| Q39305621 | Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. |
| Q38794312 | Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. |
| Q59339767 | Gut Bacterial Microbiota and its Resistome Rapidly Recover to Basal State Levels after Short-term Amoxicillin-Clavulanic Acid Treatment in Healthy Adults |
| Q54259784 | Gut Microbiome Composition Predicts Infection Risk during Chemotherapy in Children with Acute Lymphoblastic Leukemia. |
| Q29616812 | Gut Microbiota in Health and Disease |
| Q36285208 | Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome |
| Q33728322 | Gut microbiota disturbance during antibiotic therapy: a multi-omic approach |
| Q57155390 | Gut microbiota disturbance during antibiotic therapy: a multi-omic approach |
| Q35732214 | Having older siblings is associated with gut microbiota development during early childhood |
| Q41546393 | Herpesvirus in the oral cavity of children with leukaemia and its impact on the oral bacterial community profile |
| Q35059230 | High-resolution time-of-flight mass spectrometry fingerprinting of metabolites from cecum and distal colon contents of rats fed resistant starch |
| Q36364242 | High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin |
| Q103836881 | Highly multiplexed spatial mapping of microbial communities |
| Q35092538 | Host adaptive immunity alters gut microbiota |
| Q57304895 | Host genetics and microbiome associations through the lens of genome wide association studies |
| Q28069301 | How colonization by microbiota in early life shapes the immune system |
| Q35576559 | Human Clostridium difficile infection: altered mucus production and composition |
| Q35536689 | Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile |
| Q33934016 | Illumina-based analysis of microbial community diversity |
| Q34444900 | Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota |
| Q28076453 | Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC) |
| Q34981695 | Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon |
| Q36013358 | Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract |
| Q35952315 | Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice |
| Q46248072 | Impact of stress on the gut microbiome of free-ranging western lowland gorillas |
| Q28087215 | Impact of the gut microbiota on rodent models of human disease |
| Q35749738 | In-feed antibiotic effects on the swine intestinal microbiome |
| Q34279235 | Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors |
| Q39677032 | Infection control in the multidrug-resistant era: tending the human microbiome |
| Q39955450 | Influence of different probiotic lactic Acid bacteria on microbiota and metabolism of rats with dysbiosis |
| Q85657120 | Influence of penicillin on microbial diversity of the cecal microbiota in broiler chickens |
| Q35201593 | Influence of stressor-induced nervous system activation on the intestinal microbiota and the importance for immunomodulation. |
| Q35667664 | Influence of the human intestinal microbiome on obesity and metabolic dysfunction |
| Q89551586 | Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection |
| Q38010864 | Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance |
| Q26778722 | Interactions Between the Gastrointestinal Microbiome and Clostridium difficile |
| Q41696303 | Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice |
| Q35665410 | Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis |
| Q100417432 | Intestinal Clostridioides difficile Can Cause Liver Injury through the Occurrence of Inflammation and Damage to Hepatocytes |
| Q38067461 | Intestinal colonization resistance |
| Q35784067 | Intestinal microbial communities associated with acute enteric infections and disease recovery |
| Q24647611 | Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities |
| Q56348027 | Invasions of Host-Associated Microbiome Networks |
| Q54245309 | Investigating Colonization of the Healthy Adult Gastrointestinal Tract by Fungi. |
| Q35781588 | Investigation of bacterial repopulation after sinus surgery and perioperative antibiotics. |
| Q35167326 | Isolation and gut microbiota modulation of antibiotic-resistant probiotics from human feces |
| Q83240655 | Key questions to guide a better understanding of host-commensal microbiota interactions in intestinal inflammation |
| Q30416554 | Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production |
| Q35998372 | Lactobacillus rhamnosus GG Intake Modifies Preschool Children's Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use. |
| Q58786324 | Lactobacillus salivarius reverse antibiotic-induced lung defense impairment in a ventilator model |
| Q37594063 | Leptin acts independently of food intake to modulate gut microbial composition in male mice |
| Q34139803 | Life and death of deep-sea vents: bacterial diversity and ecosystem succession on inactive hydrothermal sulfides |
| Q35124886 | Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease |
| Q90158662 | Lipid and Cholesterol Homeostasis after Arsenic Exposure and Antibiotic Treatment in Mice: Potential Role of the Microbiota |
| Q34500072 | Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment |
| Q37654823 | Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system |
| Q35752912 | MIG1 Regulates Resistance of Candida albicans against the Fungistatic Effect of Weak Organic Acids. |
| Q34542021 | Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. |
| Q26795704 | Manipulating the Gut Microbiota: Methods and Challenges |
| Q91680905 | Metabolic networks of the human gut microbiota |
| Q28472543 | Metabolism of bile salts in mice influences spore germination in Clostridium difficile |
| Q36848257 | Metagenomic Analysis of Antibiotic-Induced Changes in Gut Microbiota in a Pregnant Rat Model |
| Q30920058 | Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis |
| Q92131215 | Metaproteomic investigation to assess gut microbiota shaping in newborn mice: A combined taxonomic, functional and quantitative approach |
| Q33728333 | Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection |
| Q38616073 | Microbial community response during the treatment of pharmaceutically active compounds (PhACs) in constructed wetland mesocosms |
| Q40813989 | Microbial dormancy and prevention of healthcare-associated infections |
| Q33544853 | Microbial ecological response of the intestinal flora of Peromyscus maniculatus and P. leucopus to heavy metal contamination |
| Q33842489 | Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis |
| Q37416968 | Microbial regulation of allergic responses to food. |
| Q33686568 | Microbiome disruption and recovery in the fish Gambusia affinis following exposure to broad-spectrum antibiotic |
| Q34478193 | Microbiome dynamics of human epidermis following skin barrier disruption. |
| Q39193387 | Microbiota and reproducibility of rodent models |
| Q51145755 | Microbiota inoculum composition affects holobiont assembly and host growth in Daphnia. |
| Q30276498 | Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection |
| Q93075050 | Modeling the temporal dynamics of the gut microbial community in adults and infants |
| Q93110475 | Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies |
| Q34813691 | Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans |
| Q35226623 | Multi-omics analysis of inflammatory bowel disease |
| Q34989047 | Muricholic acids inhibit Clostridium difficile spore germination and growth |
| Q26859965 | Murine models to study Clostridium difficile infection and transmission |
| Q89500835 | Myoviridae phage PDX kills enteroaggregative Escherichia coli without human microbiome dysbiosis |
| Q89964146 | Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver-Gut Axis |
| Q35721283 | Network analysis of temporal functionalities of the gut induced by perturbations in new-born piglets |
| Q34044442 | Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora |
| Q90469195 | Occurrence of β-Lactamase-Producing Gram-Negative Bacterial Isolates in Water Sources in Cali City, Colombia |
| Q36098158 | On Lactococcus lactis UL719 competitivity and nisin (Nisaplin(®)) capacity to inhibit Clostridium difficile in a model of human colon |
| Q47871652 | Osteomicrobiology: A New Cross-Disciplinary Research Field |
| Q38551892 | Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease. |
| Q37056538 | Pathways in microbe-induced obesity |
| Q34569117 | Perturbation of the human microbiome as a contributor to inflammatory bowel disease |
| Q38233839 | Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics |
| Q92124324 | Pharmaceutical exposure changed antibiotic resistance genes and bacterial communities in soil-surface- and overhead-irrigated greenhouse lettuce |
| Q92335681 | Pharmacomicrobiomics informs clinical pharmacogenomics |
| Q34970905 | Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection |
| Q91426030 | Postnatal Administration of Lactobacillus rhamnosus HN001 Ameliorates Perinatal Broad-Spectrum Antibiotic-Induced Reduction in Myelopoiesis and T Cell Activation in Mouse Pups |
| Q42908744 | Potential role of gastrointestinal microbiota composition in prostate cancer risk. |
| Q33807664 | Predictive Genomic Analyses Inform the Basis for Vitamin Metabolism and Provisioning in Bacteria-Arthropod Endosymbioses |
| Q38130321 | Probiotic approach to pathogen control in premise plumbing systems? A review |
| Q46639889 | Probiotic yeast Kluyveromyces marxianus CIDCA 8154 shows anti-inflammatory and anti-oxidative stress properties in in vivo models |
| Q34223543 | Probiotics in clostridium difficile Infection |
| Q34050235 | Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis |
| Q47153464 | Prohibition of antibiotic growth promoters has affected the genomic profiles of Lactobacillus salivarius inhabiting the swine intestine |
| Q33586133 | Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model |
| Q51172776 | Proteome changes in the initial bacterial colonist during ecological succession in an acid mine drainage biofilm community. |
| Q36096116 | Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial. |
| Q36056425 | Quantification of the relative roles of niche and neutral processes in structuring gastrointestinal microbiomes. |
| Q37502050 | Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis |
| Q34712628 | Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome |
| Q98956372 | Rainbow darter (Etheostoma caeruleum) from a river impacted by municipal wastewater effluents have altered gut content microbiomes |
| Q35560100 | Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. |
| Q36736542 | Reexamining the Germination Phenotypes of Several Clostridium difficile Strains Suggests Another Role for the CspC Germinant Receptor |
| Q91868330 | Regrowth of Microcosm Biofilms on Titanium Surfaces After Various Antimicrobial Treatments |
| Q34081385 | Regulation of the gut microbiota by the mucosal immune system in mice |
| Q35829492 | Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome |
| Q28655590 | Replenishing our defensive microbes |
| Q34153634 | Reshaping the gut microbiome with bacterial transplantation and antibiotic intake |
| Q46716905 | Responses of plasmid-mediated quinolone resistance genes and bacterial taxa to (fluoro)quinolones-containing manure in arable soil |
| Q35841405 | Rethinking "mutualism" in diverse host-symbiont communities |
| Q90436045 | Risk factors for candidemia: a prospective matched case-control study |
| Q37887810 | Role of gut microbiota in graft-versus-host disease |
| Q35201232 | Role of microbiota and innate immunity in recurrent Clostridium difficile infection. |
| Q30300874 | Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection |
| Q35448732 | Role of the commensal microbiota in normal and pathogenic host immune responses |
| Q35087507 | Role of the intestinal microbiota in resistance to colonization by Clostridium difficile |
| Q35166892 | Selective pressure of antibiotics on ARGs and bacterial communities in manure-polluted freshwater-sediment microcosms |
| Q36209781 | Sensitive and Simplified Detection of Antibiotic Influence on the Dynamic and Versatile Changes of Fecal Short-Chain Fatty Acids |
| Q33723426 | Sexually transmitted bacteria affect female cloacal assemblages in a wild bird |
| Q37848035 | Shifting the balance: antibiotic effects on host-microbiota mutualism |
| Q35153089 | Short-term effect of antibiotics on human gut microbiota |
| Q49864977 | Sieving through gut models of colonization resistance |
| Q33817613 | Significance of the microbiome in chronic obstructive pulmonary disease |
| Q36626820 | Significance of the microbiome in obstructive lung disease |
| Q54266133 | Skin bacterial flora as a potential risk factor predisposing to late bacterial infection after cross-linked hyaluronic acid gel augmentation. |
| Q34300482 | Stabilization of the murine gut microbiome following weaning |
| Q24607946 | Strategies to minimize antibiotic resistance |
| Q33530442 | Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium |
| Q41704093 | Structural and functional changes in the gut microbiota associated to Clostridium difficile infection |
| Q37902902 | Studying the Enteric Microbiome in Inflammatory Bowel Diseases: Getting through the Growing Pains and Moving Forward |
| Q34447678 | Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile |
| Q40224852 | TCDD influences reservoir of antibiotic resistance genes in murine gut microbiome |
| Q34468946 | Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice |
| Q37378699 | The Bacterial Mobile Resistome Transfer Network Connecting the Animal and Human Microbiomes |
| Q92779106 | The Cutaneous Microbiome: Implications for Dermatology Practice |
| Q35144567 | The Enteric Two-Step: nutritional strategies of bacterial pathogens within the gut |
| Q90290507 | The Gut Microbiome and Metabolome of Two Riparian Communities in the Amazon |
| Q57169434 | The Human Gut Microbiome - A Potential Controller of Wellness and Disease |
| Q96129207 | The Impact of Diet on Microbiota Evolution and Human Health. Is Diet an Adequate Tool for Microbiota Modulation? |
| Q35620754 | The Intestinal Microbiota Influences Campylobacter jejuni Colonization and Extraintestinal Dissemination in Mice |
| Q36364088 | The Murine Lung Microbiome Changes During Lung Inflammation and Intranasal Vancomycin Treatment |
| Q110756357 | The Native Dietary Habits of the Two Sympatric Bee Species and Their Effects on Shaping Midgut Microorganisms |
| Q36303174 | The altered gut microbiota in adults with cystic fibrosis |
| Q30250211 | The bovine milk microbiota: insights and perspectives from -omics studies |
| Q37988306 | The contributing role of the intestinal microbiota in stressor-induced increases in susceptibility to enteric infection and systemic immunomodulation |
| Q91350145 | The difference in nasal bacterial microbiome diversity between chronic rhinosinusitis patients with polyps and a control population |
| Q36889259 | The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge |
| Q34325764 | The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection |
| Q35607073 | The effect of early life antibiotic exposures on diarrheal rates among young children in Vellore, India |
| Q37677374 | The effects of intestinal microbial community structure on disease manifestation in IL-10-/- mice infected with Helicobacter hepaticus |
| Q38993207 | The evidence for microbiome manipulation in inflammatory arthritis |
| Q60300376 | The gut microbiome is required for full protection against acute arsenic toxicity in mouse models |
| Q35855101 | The gut microbiome, diet, and links to cardiometabolic and chronic disorders |
| Q36161048 | The gut microbiota and gastrointestinal surgery |
| Q34768911 | The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. |
| Q30584682 | The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics |
| Q38000051 | The gut microflora and its variety of roles in health and disease |
| Q28268561 | The human gut microbiome: current knowledge, challenges, and future directions |
| Q38038435 | The importance of the gut microbiota after bariatric surgery |
| Q99602925 | The influence of nasal bacterial microbiome diversity on the pathogenesis and prognosis of chronic rhinosinusitis patients with polyps |
| Q35577842 | The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection |
| Q34082793 | The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice |
| Q30248605 | The intestinal microbiome and surgical disease. |
| Q35785384 | The intestinal microbiota are necessary for stressor-induced enhancement of splenic macrophage microbicidal activity |
| Q36999628 | The intestinal microbiota in health and disease |
| Q92772665 | The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity |
| Q38050078 | The microbiome in wound repair and tissue fibrosis |
| Q33594440 | The microbiota and allergies/asthma |
| Q38799199 | The role of the commensal microbiota in adaptive and maladaptive stressor-induced immunomodulation |
| Q28284835 | The role of the microbiome in rheumatic diseases |
| Q28081348 | The sinonasal bacterial microbiome in health and disease |
| Q24634180 | The skin microbiome |
| Q35533302 | The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor |
| Q37910974 | The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus |
| Q33762817 | The treatment-naive microbiome in new-onset Crohn's disease |
| Q91450056 | Thirty Years of Lactobacillus rhamnosus GG: A Review |
| Q37713352 | Toll-like receptor stimulation induces nondefensin protein expression and reverses antibiotic-induced gut defense impairment |
| Q46347679 | Topical Antimicrobial Treatments Can Elicit Shifts to Resident Skin Bacterial Communities and Reduce Colonization by Staphylococcus aureus Competitors. |
| Q34836569 | Ulcerative Typhlocolitis Associated With Helicobacter mastomyrinus in Telomerase-Deficient Mice |
| Q95359360 | Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome |
| Q34667649 | Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks |
| Q26800289 | Understanding inflammatory bowel disease via immunogenetics |
| Q64097532 | Understanding regeneration at different scales |
| Q90604249 | Ursodeoxycholic acid (UDCA) mitigates the host inflammatory response during Clostridioides difficile infection by altering gut bile acids |
| Q88886813 | Use of a combination of in vitro models to investigate the impact of chlorpyrifos and inulin on the intestinal microbiota and the permeability of the intestinal mucosa |
| Q34360221 | Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. |
| Q84589990 | [Intestinal flora and antibiotics] |
Search more.